A retrospective, cohort study for safety and efficacy of antiplatelet‐apixaban compared to antiplatelet‐rivaroxaban in patients with AF and ACS
Latest Information Update: 10 Dec 2020
At a glance
- Drugs Apixaban (Primary) ; Rivaroxaban (Primary)
- Indications Gastrointestinal haemorrhage; Haemorrhage; Intracranial haemorrhages
- Focus Adverse reactions; Therapeutic Use
- 10 Dec 2020 New trial record